Prakash Y Khandave

Employment

Employment history is unavailable.

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (11)

• The rise of bispecific T-cell engager (BsTCE) antibodies: a potentially game-changing approach for breast cancer therapy?
  Drug Discovery Today 2026 DOI: 10.1016/j.drudis.2026.104670
  +Save
• PolyBodies for the Treatment of Respiratory Syncytial Virus Infection
  Drug Discovery Today 2026 DOI: 10.1016/j.drudis.2025.104572
  +Save
• Lignin-based biopharmaceuticals from nature to medicine: current trends, future prospects and emerging challenges
  RSC Applied Interfaces 2026 DOI: 10.1039/d5lf00377f
  +Save
• Radioligand–Antibody Conjugates: Integrating Antibody Engineering, Chelator Chemistry, and Radioligands for Precision Theranosis
  Molecular Diagnosis & Therapy 2025 DOI: 10.1007/s40291-025-00825-2
  +Save
• Photosensitizer-Antibody Conjugates (PhotoBodies): Emerging Frontiers in the Field of Theranostics
  Pharmaceutical Research 2025 DOI: 10.1007/s11095-025-03975-4
  +Save
• Chemotherapeutic Drug—Antibody Conjugates (ChemoBodies): Recent Advances and Future Directions
  Current Oncology Reports 2025 DOI: 10.1007/s11912-025-01713-y
  +Save
• Challenges and advances in the development of antidotes against A-series nerve agents
  Archives of Toxicology 2025 DOI: 10.1007/s00204-025-04216-8
  +Save
• Human Paraoxonase 1: From Bloodstream Enzyme to Disease Fighter & Therapeutic Intervention
  Current Protein & Peptide Science 2024 DOI: 10.2174/0113892037335325241011162207
  +Save
• Role of paraoxonase 1 in organophosphate G-series nerve agent poisoning and future therapeutic strategies
  Archives of Toxicology 2024 DOI: 10.1007/s00204-024-03884-2
  +Save
• Warfare Nerve Agents and Paraoxonase-1 as a Potential Prophylactic Therapy against Intoxication
  Protein & Peptide Letters 2024 DOI: 10.2174/0109298665284293240409045359
  +Save